VivoSim Labs, Inc. (VIVS)

VivoSim Labs, Inc. (VIVS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.6M; returns 1 day -6.8%, 1 week -5.4%, 1 year -93.3%.

VivoSim Labs, Inc. (Nasdaq: VIVS) is a pharmaceutical and biotechnology services company focused on providing testing of drugs and drug candidates using 3D human tissue models of the liver and intestine. They offer liver and intestinal toxicology insights using new approach methodologies (NAM) designed as non-animal, human-relevant systems.

Groups VIVS belongs to

• Biotechnology
• Life Sciences
• Pharmaceuticals
• AI in Healthcare
• Life Sciences Tools & Services
• Artificial Intelligence
• Drug Discovery
• Healthcare Technology
• Contract Development and Manufacturing Organizations (CDMO)

VIVS financial model: income statement, cash flow and balance sheet